With a population of more than 1.4 billion people, China has emerged as one of the largest and most lucrative markets for cosmetics worldwide, but entering this market has unique challenges, particularly in regard to regulatory requirements. China introduced “Cosmetic Supervision and Administration Regulation” (CSAR) in 2020, a new set of regulations for cosmetics that is expected to be largely implemented by 2024 and is bringing significant changes to the cosmetics industry in China. As companies develop their internal compliance policies and practices, it is critical to stay informed and understand the implications of these new regulatory requirements.
Join PCPC on November 8 for a webinar that highlights the latest updates and key issues related to China’s cosmetics reform and provides strategies for navigating the changing regulatory landscape. John Balzano, partner at Covington and Burling, will share valuable practical insights to help companies confront the challenges of CSAR implementation now and in the year ahead.
About the Speaker
John Balzano
Partner, Covington & Burling
John Balzano has more than 19 years of experience with legal and regulatory issues related to China, particularly with regard to products regulated by the State Administration for Market Regulation, the National Medical Products Administration (NMPA) and other agencies in China, including drugs, devices and cosmetics, as well as food products and other agriculture, animal and healthcare products and services.
He assists clients with developing strategies to obtain pre-market approvals for these products, including clinical development, understanding relevant pricing and reimbursement policies, and reviewing distribution and promotional plans.
The cost is $295 for PCPC members, $495 for nonmembers.
Can’t make it to the webinar? Register and receive the recording in your inbox. For registration questions, please contact Shirley Gibbs.